HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -33.3% | 2,900 | 0.0% | 0.00% | – |
| Q2 2023 | $3 | -25.0% | 2,900 | 0.0% | 0.00% | – |
| Q1 2023 | $4 | -42.9% | 2,900 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $7 | -99.9% | 2,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $12,000 | +33.3% | 2,900 | -31.5% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -79.1% | 4,236 | -59.8% | 0.00% | -50.0% |
| Q1 2022 | $43,000 | +65.4% | 10,536 | +263.3% | 0.00% | +100.0% |
| Q4 2021 | $26,000 | -16.1% | 2,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $31,000 | -31.1% | 2,900 | -3.3% | 0.00% | -50.0% |
| Q2 2021 | $45,000 | +50.0% | 3,000 | -45.5% | 0.00% | +100.0% |
| Q1 2021 | $30,000 | +400.0% | 5,500 | +243.8% | 0.00% | – |
| Q4 2020 | $6,000 | -95.2% | 1,600 | -93.7% | 0.00% | -100.0% |
| Q3 2020 | $124,000 | +13.8% | 25,449 | +3.0% | 0.01% | +14.3% |
| Q2 2020 | $109,000 | -14.2% | 24,700 | -24.9% | 0.01% | +16.7% |
| Q1 2020 | $127,000 | +47.7% | 32,900 | +311.2% | 0.01% | -25.0% |
| Q3 2019 | $86,000 | +50.9% | 8,000 | -38.0% | 0.01% | +60.0% |
| Q2 2019 | $57,000 | +307.1% | 12,900 | +760.0% | 0.01% | +400.0% |
| Q1 2019 | $14,000 | -62.2% | 1,500 | -46.4% | 0.00% | -75.0% |
| Q4 2018 | $37,000 | 0.0% | 2,800 | +27.3% | 0.00% | +100.0% |
| Q3 2018 | $37,000 | -15.9% | 2,200 | -84.3% | 0.00% | -33.3% |
| Q2 2018 | $44,000 | -86.7% | 14,000 | -60.4% | 0.00% | -89.7% |
| Q1 2018 | $331,000 | +549.0% | 35,343 | +57.8% | 0.03% | +1350.0% |
| Q4 2017 | $51,000 | -29.2% | 22,400 | +65.7% | 0.00% | 0.0% |
| Q3 2017 | $72,000 | -75.3% | 13,516 | -67.8% | 0.00% | -80.0% |
| Q2 2017 | $291,000 | +334.3% | 41,950 | +399.9% | 0.01% | +233.3% |
| Q1 2017 | $67,000 | -92.6% | 8,391 | -95.3% | 0.00% | -90.9% |
| Q4 2016 | $907,000 | +75.4% | 179,582 | +98.3% | 0.03% | +43.5% |
| Q3 2016 | $517,000 | +155.9% | 90,559 | +199.4% | 0.02% | +130.0% |
| Q2 2016 | $202,000 | -56.9% | 30,245 | -52.3% | 0.01% | -66.7% |
| Q1 2016 | $469,000 | +81.8% | 63,442 | +134.4% | 0.03% | +114.3% |
| Q4 2015 | $258,000 | – | 27,067 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |